Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals. (TPQ BDI SSQOL)

This study has been completed.
Information provided by (Responsible Party):
d_yarnitsky, Rambam Health Care Campus Identifier:
First received: February 15, 2009
Last updated: October 24, 2011
Last verified: October 2011

Personality type as a predictor to develop depression and reduction in quality of life among stroke survivals.

Quality of Life
Personality Type

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Personality Type as a Predictor to Develop Depression and Reduction in Quality of Life Among Stroke Survivals.

Further study details as provided by Rambam Health Care Campus:

Primary Outcome Measures:
  • Depression [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • QOL post stroke [ Time Frame: 1-3 month post stroke ] [ Designated as safety issue: No ]

Enrollment: 85
Study Start Date: November 2007
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
1. Harm Avoidance
Personality type
2. Reward Dependence
Personality type
3. Novelty Seeking
Personality type


Ages Eligible for Study:   40 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Stroke ( TIA, CVA, ICH ) patients


Inclusion Criteria:

  • any stroke,
  • age 40-90,
  • able to sigh informed concent,
  • able to fill in the questionnaires.

Exclusion Criteria:

  • non stroke,
  • previous depression,
  • not able to give consent or answer the questions.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00845455

Sponsors and Collaborators
Principal Investigator: David - Yarnitsky, Prof.
  More Information

No publications provided

Responsible Party: d_yarnitsky, MD, Rambam Health Care Campus Identifier: NCT00845455     History of Changes
Other Study ID Numbers: TPQStroke03CTIL
Study First Received: February 15, 2009
Last Updated: October 24, 2011
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Behavioral Symptoms processed this record on March 03, 2015